Paper29037232
A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice.
Aston WJ and 5 others. BMC Cancer, 2017. Cited by 153 papers, by iCite.
Cite this record
ConductScience Library. A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice. Papers, record 29037232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29037232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Etoposide | Major topic |
| Maximum Tolerated Dose | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Disease Models, Animal | |
| Dose-Response Relationship, Drug | |
| Humans | |
| Mice |
Source PubMed
References83
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18695136 | Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer. | J Natl Cancer Inst | 2008 | https://conductscience.org/library/papers/18695136 | PubMed |
| 2 | 26188166 | Ondansetron attenuates co-morbid depression and anxiety associated with obesity by inhibiting the biochemical alterations and improving serotonergic neurotransmission. | Pharmacol Biochem Behav | 2015 | https://conductscience.org/library/papers/26188166 | PubMed |
| 3 | 10658523 | Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. An EORTC Gynaecological Cancer Cooperative Group study. | Eur J Cancer | 1999 | https://conductscience.org/library/papers/10658523 | PubMed |
| 4 | 24184695 | The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting. | Eur J Pharmacol | 2014 | https://conductscience.org/library/papers/24184695 | PubMed |
| 5 | 26968813 | In vitro and in vivo effects of a recombinant anti-PSMA immunotoxin in combination with docetaxel against prostate cancer. | Oncotarget | 2016 | https://conductscience.org/library/papers/26968813 | PubMed |
| 6 | 10458234 | Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study. | J Clin Oncol | 1999 | https://conductscience.org/library/papers/10458234 | PubMed |
| 7 | 12802024 | Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. | N Engl J Med | 2003 | https://conductscience.org/library/papers/12802024 | PubMed |
| 8 | 26724433 | Chemotherapy and immunotherapy: mapping the road ahead. | Curr Opin Immunol | 2016 | https://conductscience.org/library/papers/26724433 | PubMed |
| 9 | 21383056 | Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. | J Exp Med | 2011 | https://conductscience.org/library/papers/21383056 | PubMed |
| 10 | 15899580 | Cyclophosphamide decreases the number, percentage and the function of CD25+ CD4+ regulatory T cells, which suppress induction of contact hypersensitivity. | J Dermatol Sci | 2005 | https://conductscience.org/library/papers/15899580 | PubMed |
| 11 | 24259502 | Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis. | J Immunol | 2014 | https://conductscience.org/library/papers/24259502 | PubMed |
| 12 | 18540827 | Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide. | Crit Rev Immunol | 2008 | https://conductscience.org/library/papers/18540827 | PubMed |
| 13 | 89906 | Effects of systemically administered bleomycin or adriamycin with local hyperthermia on primary tumor and lung metastases. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/89906 | PubMed |
| 14 | 22001253 | Effects of multiple doses of cyclophosphamide on mouse testes: accessing the germ cells lost, and the functional damage of stem cells. | Reprod Toxicol | 2011 | https://conductscience.org/library/papers/22001253 | PubMed |
| 15 | 21765211 | Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice. | J Clin Invest | 2011 | https://conductscience.org/library/papers/21765211 | PubMed |
| 16 | 6387060 | The importance of dose intensity in chemotherapy of metastatic breast cancer. | J Clin Oncol | 1984 | https://conductscience.org/library/papers/6387060 | PubMed |
| 17 | 9815644 | Docetaxel enhances tumor radioresponse in vivo. | Clin Cancer Res | 1997 | https://conductscience.org/library/papers/9815644 | PubMed |
| 18 | 19436029 | Dose escalation methods in phase I cancer clinical trials. | J Natl Cancer Inst | 2009 | https://conductscience.org/library/papers/19436029 | PubMed |
| 19 | 9554586 | Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid. | Cancer Chemother Pharmacol | 1998 | https://conductscience.org/library/papers/9554586 | PubMed |
| 20 | 9500186 | Oral versus intraperitoneal administration of irinotecan in the treatment of human neuroblastoma in nude mice. | Cancer Lett | 1998 | https://conductscience.org/library/papers/9500186 | PubMed |
Cited by104
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 153 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42861467 | Preclinical Pharmacokinetic-Pharmacodynamic Modeling of Antibody Nanoconjugates for Breast Cancer Treatment. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/42861467 | PubMed |
| 42573677 | A novel tetrahydrocurcumin derivative as a potential anti-colorectal cancer agent: studies on its design, synthesis, and in vitro and in vivo biological evaluation. | Nat Prod Bioprospect | 2026 | https://conductscience.org/library/papers/42573677 | PubMed |
| 42503515 | Bacteria-mimicking cancer cells reprogram macrophages via multiple pattern recognition receptor pathways for cancer immunotherapy. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42503515 | PubMed |
| 42454521 | Differential impact of cancer- and chemotherapy-induced cachexia: a comparative analysis in a preclinical model of colorectal cancer by biological sex. | Am J Physiol Endocrinol Metab | 2026 | https://conductscience.org/library/papers/42454521 | PubMed |
| 42384606 | In Silico Drug Repositioning Identifies SYK Kinase Inhibitors as Potential Neuroprotective Agents for Ataxia-Telangiectasia. | Chem Biol Drug Des | 2026 | https://conductscience.org/library/papers/42384606 | PubMed |
| 42376386 | Determination of the optimal cisplatin dose to induce anemia in streptozotocin-nicotinamide-induced type 2 diabetic rats: A preliminary study. | Open Vet J | 2026 | https://conductscience.org/library/papers/42376386 | PubMed |
| 42099027 | Evaluation of Arabica coffee pulp extract on sperm quality and hematology in cyclophosphamide-treated rats. | Environ Anal Health Toxicol | 2026 | https://conductscience.org/library/papers/42099027 | PubMed |
| 41824583 | Microrobotic copper-rich electrochemical interfacing for targeted cancer theranostics in the gut. | Sci Adv | 2026 | https://conductscience.org/library/papers/41824583 | PubMed |
| 41549226 | All-PEG-Like Block Copolymers Self-Assemble into Stealth Nanocarriers for Drug Delivery. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41549226 | PubMed |
| 41547980 | Influences of formulations and administration routes on docetaxel tissue distribution in mice. | Sci Rep | 2026 | https://conductscience.org/library/papers/41547980 | PubMed |
| 41451844 | Loss-of-function genetic screen unveils synergistic efficacy of PARG inhibition with combined 5-fluorouracil and irinotecan treatment in colorectal cancer. | Clin Transl Med | 2025 | https://conductscience.org/library/papers/41451844 | PubMed |
| 41350954 | Enhanced Efficacy and Safety: Cabazitaxel Nanodispersions as a Novel Therapeutic Platform against Prostate Cancer. | AAPS PharmSciTech | 2025 | https://conductscience.org/library/papers/41350954 | PubMed |
| 41346803 | Leveraging topoisomerase II-mediated DNA damage: repurposing etoposide as a lead compound for apicomplexan parasite control. | Front Vet Sci | 2025 | https://conductscience.org/library/papers/41346803 | PubMed |
| 41186408 | Optogenetic Cancer Therapy Using the Light-Driven Outward Proton Pump Rhodopsin Archaerhodopsin-3 (AR3). | J Am Chem Soc | 2025 | https://conductscience.org/library/papers/41186408 | PubMed |
| 41154612 | The Convergence of Biology and Material Science: Biomolecule-Driven Smart Drug Delivery Systems. | Biomolecules | 2025 | https://conductscience.org/library/papers/41154612 | PubMed |
| 41148819 | The Immunomodulatory Role of Gemcitabine in Triple Negative Breast Cancer. | Cells | 2025 | https://conductscience.org/library/papers/41148819 | PubMed |
| 40940745 | Doxorubicin-Loaded Nanoparticle Treatment Enhances Diffuse Large B-Cell Lymphoma Cell Death. | Cells | 2025 | https://conductscience.org/library/papers/40940745 | PubMed |
| 40792484 | Three Is Better than One: A Multimetal Complex that Triggers Immunogenic Cell Death. | Angew Chem Int Ed Engl | 2025 | https://conductscience.org/library/papers/40792484 | PubMed |
| 40751101 | Chemotherapy alters radiosensitivity and GRPR expression of prostate and breast cancer cells. | EJNMMI Res | 2025 | https://conductscience.org/library/papers/40751101 | PubMed |
| 40708972 | Synergistic drug combination screening using a nanodroplet processing platform to enhance neuroblastoma treatment in TH-MYCN transgenic mice. | Bioeng Transl Med | 2025 | https://conductscience.org/library/papers/40708972 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL17A | 3605 | PubTator's text mining | https://conductscience.org/library/genes/3605 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29037232
GET https://conductscience.org/api/papers/v1/29037232/references?page=2